Perimenopause at 40: When It Starts Early and What to Do

You’re 40. Maybe 38 or 42. Your periods are starting to feel different. Your sleep is off. Your mood is doing something it hasn’t done before. You mention it to your GP who tells you you’re too young for menopause and runs a blood test that comes back normal.

You go home confused. You feel the same. The symptoms don’t care what the blood test said.

Here is what your GP may not have told you: perimenopause commonly starts in the early 40s. It can start in the late 30s. “Too young” is not a diagnosis. And a single FSH blood test taken at one point in time is a poor tool for identifying the early perimenopausal transition — because FSH fluctuates wildly during this phase and can be normal even when you’re clearly transitioning.

What “Early Perimenopause” Means

The menopause transition is defined officially by The Menopause Society as beginning when cycles become variable — either shorter or longer than your usual pattern by more than 7 days. This typically occurs in the late 40s, but the hormonal changes that precede cycle variability begin earlier.

Early perimenopause (early 40s) and premature perimenopause (late 30s) are real. Premature ovarian insufficiency (POI) — when the ovaries begin failing before 40 — affects roughly 1% of women and has significant health implications beyond symptom management.

You are not too young to be in perimenopause at 40. You may be at the earlier end of the normal range, but the normal range starts well before 45.

Why Blood Tests Can Miss Early Perimenopause

FSH (follicle-stimulating hormone) is the marker typically tested to assess menopausal status. Elevated FSH indicates the ovaries are working harder to produce estrogen — a sign of declining ovarian reserve. But in early perimenopause, FSH fluctuates dramatically from cycle to cycle and even within a single cycle. A test taken on day 3 of one cycle might be elevated; the next month it might be normal. This is the transition — not a stable hormonal state but an erratic one.

Estradiol (estrogen) also fluctuates dramatically in early perimenopause — often in large swings that produce the intensely symptomatic period before cycles become obviously irregular.

The practical implication: one normal FSH does not rule out perimenopause. The diagnosis in the early transition is clinical — based on symptoms, cycle history, and age — not exclusively on blood results.

What Early Perimenopause Feels Like

Early symptoms before cycle changes are often neurological and mood-related: new anxiety, sleep disruption, low mood, brain fog, and irritability. These appear because progesterone tends to decline before estrogen does — removing its calming, GABA-supporting effect on the brain.

Some women experience physical symptoms first: heavier or more irregular periods, premenstrual symptoms that are more intense than before, breast tenderness, and headaches that track with the cycle more clearly than in the past.

Hot flashes and night sweats may be mild or absent in early perimenopause — they tend to worsen as the transition progresses and estrogen drops more significantly.

Why Early Perimenopause Matters Medically

The hormonal transition carries real health implications beyond symptom management, and these implications are more significant the earlier the transition begins:

Bone density. The decade of accelerated bone loss begins with the estrogen decline of perimenopause. Earlier transition means more years of estrogen-deficient bone remodelling. A baseline DEXA scan is reasonable for women experiencing early perimenopause.

Cardiovascular health. Estrogen has cardioprotective effects. Earlier loss of estrogen is associated with higher cardiovascular risk over a lifetime. The “timing hypothesis” in HRT research is particularly relevant here — starting HRT early, during the transition window, appears to confer cardiovascular protection that starting it later does not.

Cognitive health. Earlier and longer exposure to estrogen deficiency during the transition may affect long-term cognitive outcomes. Starting HRT during the transition is associated with better cognitive outcomes than starting after a significant gap.

This is not a reason to panic. It is a reason to take your symptoms seriously, seek proper assessment, and have an informed conversation about treatment sooner rather than later.

What to Do

Track your cycles and symptoms meticulously for two to three months. Bring this data to your appointment. Ask for a full hormonal panel including FSH, estradiol, testosterone, thyroid function, ferritin, and vitamin D — not just a single FSH.

If you are dismissed on the basis of being “too young,” you are entitled to a second opinion. A menopause specialist — rather than a general GP — will have the training to interpret fluctuating hormonal results in the context of your full symptom picture. If your symptoms are affecting your quality of life, you don’t need to wait until you’re 48 and clearly cycling irregularly to be taken seriously.

For women with premature ovarian insufficiency (symptoms before 40), HRT is recommended not primarily as a quality-of-life intervention but as a health-protective measure for bone and cardiovascular health — and is generally recommended until at least the average age of natural menopause (51-52).

Last reviewed: July 2026 · SecondFyre Editorial

This is not your slow down. This is your second fyre.